JCVI announces advice for 2024 spring COVID-19 vaccine programme
The committee has advised that the vaccine should be given to those at the highest risk
Read Moreby Jen Brogan | Feb 8, 2024 | News | 0
The committee has advised that the vaccine should be given to those at the highest risk
Read Moreby Jen Brogan | Nov 2, 2023 | News | 0
The NHS has already delivered over 20 million winter vaccines this year
Read Moreby PharmaTimes | Dec 7, 2021 | News | 0
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.
Read Moreby Lucy Parsons | Mar 19, 2021 | News | 0
MHRA and EMA conclude the vaccine’s benefits continue to outweigh risks
Read Moreby Lucy Parsons | Jan 19, 2021 | News | 0
NHS is now offering vaccines to another two priority groups in the UK
Read Moreby Lucy Parsons | Aug 4, 2020 | News | 0
New deal with Wockhardt boosts capacity at the crucial ‘fill and finish’ stage
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479